No matches

63 search results for: asthma

Expert

Frederik Trinkmann, MD

Frederik Trinkmann, MD, is an associate professor at Heidelberg University in Heidelberg, Germany. Additionally, he is an executive senior physician in the department of pulmonology and respiratory medicine and director of the Asthma Outpatient Clinic at the Thoraxklinik within Heidelberg University Hospital. Additionally, Professor Trinkmann serves as a research associate in the department of biomedical informatics in the Center for Preventative Medicine and Digital Health Baden-Württemberg at the University Medical Center Mannheim in Mannheim, Germany.

Type 2 Inflammation

AANP 2025 | Atopic Diseases & a Case-Based Panel of Nurse Practitioners

45 min

videoanimation

Experts from different specialties use a case-based discussion to understand type 2 inflammatory diseases from a nurse practitioner perspective.

Dermatology

The Role of Type 2 Inflammation in Multiple Disease Trajectories

5 min

Infographic

How type 2 inflammation drives atopic dermatitis and underlies other atopic diseases across multiple disease trajectories including the atopic march.

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: LebanonChange country/region